ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,144Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 252

$939K Total Retail Price of All Prescriptions

Rank: 15 out of 252

582 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 582 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 582 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 8,857 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LISINOPRIL 618 360 1 3
HYDROCODONE-ACETAMINOPHEN 532 263 S3 2 5
SIMVASTATIN 515 333 3 2
NEXIUM 507 186 4 23
LEVOTHYROXINE SODIUM 462 274 5 1
OMEPRAZOLE 436 308 6 6
TRAMADOL HCL 399 198 7 17
FUROSEMIDE 386 240 8 7
ZOLPIDEM TARTRATE 303 105 9 21
GABAPENTIN 268 122 10 11
ATENOLOL 268 186 10 18
METFORMIN HCL 260 124 12 9
METOPROLOL TARTRATE 242 159 13 10
POTASSIUM CHLORIDE 237 180 14 8
MELOXICAM 235 134 15 20
HYDROCHLOROTHIAZIDE 219 132 16 13
PROAIR HFA 207 77 17 54
SERTRALINE HCL 200 112 18 27
ACETAMINOPHEN-CODEINE 187 73 S3 19 117
FLUOXETINE HCL 180 70 20 57
TRAZODONE HCL 176 94 21 31
DIOVAN 174 92 22 38
CYMBALTA 166 42 23 45
CYCLOBENZAPRINE HCL 159 77 R 24 51
LOSARTAN POTASSIUM 159 98 24 24
ESTRADIOL 158 79 R 26 76
CARVEDILOL 157 113 27 22
AMLODIPINE BESYLATE 156 114 28 4
AMOXICILLIN 148 90 29 122
CITALOPRAM HBR 144 62 30 15
LYRICA 141 58 31 66
GLYBURIDE-METFORMIN HCL 141 94 R 31 82
METOPROLOL SUCCINATE 138 93 33 19
CLOPIDOGREL 129 86 34 29
PRAVASTATIN SODIUM 120 93 35 12
AZITHROMYCIN 119 76 36 37
DIOVAN HCT 113 63 37 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 80 38 25
RANITIDINE HCL 107 33 39 48
CIPROFLOXACIN HCL 100 75 40 61
CRESTOR 100 27 40 34
WARFARIN SODIUM 99 93 42 14
VENLAFAXINE HCL ER 97 24 43 105
GLIPIZIDE 94 71 44 52
DIGOXIN 93 66 45 44
ACTOS 90 51 46 135
PLAVIX 90 60 46 43
ESCITALOPRAM OXALATE 85 34 48 56
FLUTICASONE PROPIONATE 83 37 49 36
CARISOPRODOL 82 0 R 50 70
LEVOFLOXACIN 81 56 51 79
PREMARIN 77 31 R 52 116
QUETIAPINE FUMARATE 76 17 53 77
PREDNISONE 76 66 53 42
METOCLOPRAMIDE HCL 71 53 55 110
TRIAMTERENE-HCTZ 70 65 56 33
ROPINIROLE HCL 70 39 56 84
DOXYCYCLINE HYCLATE 69 38 58 92
PROMETHAZINE HCL 67 30 R 59 85
NAPROXEN 66 44 60 96
LANTUS SOLOSTAR 64 34 61 109
TIZANIDINE HCL 63 26 62 129
AMITRIPTYLINE HCL 60 31 R 63 46
LANTUS 60 21 63 55
POLYETHYLENE GLYCOL 3350 59 42 65 67
LOSARTAN-HYDROCHLOROTHIAZIDE 58 45 66 49
TOPIRAMATE 57 0 67 151
LUNESTA 57 23 67 286
NOVOLOG 56 21 69 106
TRIAMCINOLONE ACETONIDE 55 32 70 147
CLONIDINE HCL 55 14 70 35
SPIRONOLACTONE 55 18 70 53
SPIRIVA 54 46 73 68
ATORVASTATIN CALCIUM 53 42 74 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 25 74 87
ALENDRONATE SODIUM 52 39 76 32
ISOSORBIDE MONONITRATE ER 50 37 77 50
ENALAPRIL MALEATE 50 35 77 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.